145 related articles for article (PubMed ID: 32026559)
1. Increasing use of positron emission tomography among medicare beneficiaries undergoing radical cystectomy.
Maganty A; Turner RM; Yabes JG; Heron DE; Gingrich JR; Davies BJ; Jacobs BL
Eur J Cancer Care (Engl); 2020 Jul; 29(4):e13230. PubMed ID: 32026559
[TBL] [Abstract][Full Text] [Related]
2. Variations in Preoperative Use of Bone Scan Among Medicare Beneficiaries Undergoing Radical Cystectomy.
Turner RM; Yabes JG; Davies BJ; Heron DE; Jacobs BL
Urology; 2017 May; 103():84-90. PubMed ID: 28238757
[TBL] [Abstract][Full Text] [Related]
3. [(18)F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy.
Kollberg P; Almquist H; Bläckberg M; Cronberg C; Garpered S; Gudjonsson S; Kleist J; Lyttkens K; Patschan O; Liedberg F
Scand J Urol; 2015; 49(4):296-301. PubMed ID: 25623843
[TBL] [Abstract][Full Text] [Related]
4. Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors.
Honma I; Masumori N; Sato E; Takayanagi A; Takahashi A; Itoh N; Tamagawa M; Sato MA; Tsukamoto T
Urology; 2004 Oct; 64(4):744-8. PubMed ID: 15491713
[TBL] [Abstract][Full Text] [Related]
5. Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study.
Necchi A; Pond GR; Smaldone MC; Pal SK; Chan K; Wong YN; Viterbo R; Sonpavde G; Harshman LC; Crabb S; Alva A; Chowdhury S; De Giorgi U; Srinivas S; Agarwal N; Bamias A; Baniel J; Golshayan AR; Ladoire S; Sternberg CN; Cerbone L; Yu EY; Bellmunt J; Vaishampayan U; Niegisch G; Hussain S; Bowles DW; Morales-Barrera R; Milowsky MI; Theodore C; Berthold DR; Sridhar SS; Powles T; Rosenberg JE; Galsky MD;
Eur Urol Focus; 2018 Dec; 4(6):937-945. PubMed ID: 28753879
[TBL] [Abstract][Full Text] [Related]
6. Contemporary 90-day mortality rates after radical cystectomy in the elderly.
Schiffmann J; Gandaglia G; Larcher A; Sun M; Tian Z; Shariat SF; McCormack M; Valiquette L; Montorsi F; Graefen M; Saad F; Karakiewicz PI
Eur J Surg Oncol; 2014 Dec; 40(12):1738-45. PubMed ID: 25454826
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.
Vetterlein MW; Wankowicz SAM; Seisen T; Lander R; Löppenberg B; Chun FK; Menon M; Sun M; Barletta JA; Choueiri TK; Bellmunt J; Trinh QD; Preston MA
Cancer; 2017 Nov; 123(22):4346-4355. PubMed ID: 28743155
[TBL] [Abstract][Full Text] [Related]
8. Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer.
Macleod LC; Yabes JG; Yu M; Fam MM; Hale NE; Turner RM; Lopa SH; Gingrich JR; Borza T; Skolarus TA; Davies BJ; Jacobs BL
Urol Oncol; 2019 Jul; 37(7):462-469. PubMed ID: 31053530
[TBL] [Abstract][Full Text] [Related]
9. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
[TBL] [Abstract][Full Text] [Related]
10. Unconventional Bladder Preservation: Factors Predicting Failure to Receive Definitive Surgery following Chemotherapy for Nonmetastatic Muscle Invasive Bladder Cancer in the National Cancer Database.
Kapadia AA; Martinez Acevedo A; Liu JJ; Garzotto M; Conlin M; Amling C; Kopp RP
J Urol; 2018 Sep; 200(3):535-540. PubMed ID: 29551404
[TBL] [Abstract][Full Text] [Related]
11. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
12. Use of radical cystectomy for patients with invasive bladder cancer.
Gore JL; Litwin MS; Lai J; Yano EM; Madison R; Setodji C; Adams JL; Saigal CS;
J Natl Cancer Inst; 2010 Jun; 102(11):802-11. PubMed ID: 20400716
[TBL] [Abstract][Full Text] [Related]
13. Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer.
Porter MP; Kerrigan MC; Donato BM; Ramsey SD
Urol Oncol; 2011; 29(3):252-8. PubMed ID: 19450992
[TBL] [Abstract][Full Text] [Related]
14. [Clinical outcomes after modified radical cystectomy in the treatment of 188 patients with invasive bladder cancer].
Yu SL; Hou GL; Zhou FJ; Liu ZW; Han H; Qin ZK; Li YH; Zhang ZL; Yao K
Ai Zheng; 2009 May; 28(5):500-5. PubMed ID: 19624878
[TBL] [Abstract][Full Text] [Related]
15. Increasing utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer in the United States.
Keegan KA; Zaid HB; Patel SG; Chang SS
Curr Urol Rep; 2014 Apr; 15(4):394. PubMed ID: 24566815
[TBL] [Abstract][Full Text] [Related]
16. Determinants of radical cystectomy operative time.
Filson CP; Tan HJ; Chamie K; Laviana AA; Hu JC
Urol Oncol; 2016 Oct; 34(10):431.e17-24. PubMed ID: 27372282
[TBL] [Abstract][Full Text] [Related]
17. Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?
Brant A; Kates M; Chappidi MR; Patel HD; Sopko NA; Netto GJ; Baras AS; Hahn NM; Pierorazio PM; Bivalacqua TJ
Urol Oncol; 2017 Jan; 35(1):34.e17-34.e25. PubMed ID: 27639777
[TBL] [Abstract][Full Text] [Related]
18. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
[TBL] [Abstract][Full Text] [Related]
19. Unmet informational and supportive care needs of patients following cystectomy for bladder cancer based on age, sex, and treatment choices.
Mohamed NE; Pisipati S; Lee CT; Goltz HH; Latini DM; Gilbert FS; Wittmann D; Knauer CJ; Mehrazin R; Sfakianos JP; McWilliams GW; Quale DZ; Hall SJ
Urol Oncol; 2016 Dec; 34(12):531.e7-531.e14. PubMed ID: 27449687
[TBL] [Abstract][Full Text] [Related]
20. Effect of variant histology presence and squamous differentiation on oncological results and patient's survival after radical cystectomy.
Sefik E; Celik S; Basmaci I; Yarımoglu S; Bozkurt IH; Yonguc T; Gunlusoy B
Arch Ital Urol Androl; 2018 Sep; 90(3):172-175. PubMed ID: 30362682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
